Ron Hj Mathijssen

50PUBLICATIONS
212CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AllergyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Aug 05, 2026
Neurological complications induced by checkpoint inhibitors: characterising the clinical spectra.

|Jun 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study.

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

|May 14, 2026
Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice.

|May 06, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC after Immune Checkpoint Blockade.

Pageof 9

Frequent Collaborators

9 joint publications

Esther Oomen-de Hoop

8 joint publications

Henk-Jan Guchelaar

6 joint publications

Ron H N van Schaik

6 joint publications

Jesse J Swen